Despite continued struggles for next-gen biofuel makers, VCs are still putting money into startups, particularly when it comes to follow-on rounds. EdeniQ announced that it has raised another round of more than $30 million from investors including Kleiner Perkins, Draper Fisher Jurvetson, and The Westly Group. Read more »
Biofuel and biochemical companies continue to file to go public. But the reality is that the stocks of most of the publicly-traded biochemical and biofuel companies have suffered this year. Here’s the latest on the biofuel firms’ earnings from last week and stock prices. Read more »
Kleiner Perkins has another biofuel and biochemical company up its sleeve. On Tuesday, a Kleiner-backed startup called Renmatix, which makes sugar from biomass that can be turned into biofuel and biochemicals, came out of stealth during an event in King of Prussia, Pennsylvania. Read more »
After the great market sell-off yesterday, stocks are rebounding slightly on Tuesday, including many of the greentech stocks that took a beating yesterday. But most of them are only up slightly. Here’s the latest: Read more »
Tech stocks took a beating on Monday morning, the first day of trading after Standard & Poor downgraded the credit ratings of credit agencies. At the same time, greentech stocks — from solar to biofuels to smart grid — fell alongside the weak macro economic news. Read more »
Biofuel firm KiOR, which debuted on the Nasdaq this morning priced at $15 per share, also closed the day at $15 per share — in other words, as flat as a Britney Spear’s high note. Read more »
Next-gen biofuel firm Amyris reported its first earnings results as a public company late Thursday, and the results were as expected: given the company isn’t yet in commercial production its revenues are flat and it’s still losing money. Read more »
How’s next-gen biofuel maker Amyris faring on its first day of trading? Not bad. Not rocking, but pretty steady. The company started trading at $16.50, traded as high as $17.40 by mid-morning, but dropped back down around $16.50 by the late afternoon. Read more »
Amyris has priced shares for its IPO at $16, below its previously anticipated range or $18 to $20. At least 5.3 million of Amyris’ shares will start trading later today under the symbol AMRS. The IPO has raised $84.8 million. Read more »
